AI背景下《新药开发设计》教学改革研究

Teaching Reform Research of New Drug Development and Design in the Context of AI

摘要: 随着人工智能(AI)技术的普及，传统的《新药开发设计》课程在教学方法和教学内容上都受到一定的冲击，比如AI整合不足、相关技术更新慢、重理论轻实践等。构建AI驱动的课程体系，并探索强化实践与创新的教学模式，具有现实紧迫性。改革后的课程强调AI技术在靶点识别、先导化合物优化和临床前评价等关键环节的融合，倡导师生共学共建的教学机制，突出项目驱动和实践训练，旨在培养既精通药学专业知识，又熟练掌握AI技术，具备跨学科整合能力和创新精神的复合型药物研发人才。

Abstract: With the widespread adoption of artificial intelligence (AI) technology, the traditional New Drug Development and Design course has faced challenges in both teaching methods and content, such as insufficient AI integration, slow updates in relevant technologies, and an emphasis on theory over practice. The construction of an AI-driven curriculum system and the exploration of teaching models that enhance practical skills and innovation are of urgent practical importance. The reformed curriculum emphasizes the integration of AI technology in key stages such as target identification, lead compound optimization, and preclinical evaluation. It advocates for a teaching mechanism where both teachers and students learn and build together, focusing on project-driven approaches and practical training. The goal is to cultivate interdisciplinary, innovative pharmaceutical R&D talents who are not only proficient in pharmaceutical knowledge but also skilled in AI technologies and capable of integrating expertise across fields.